FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 51 through 100 of 153

PHARMACEUTICAL PREPARATIONS - SIC # 2834

Ticker Exchange Company Financial Reports SIC #
GRML Nasdaq Greenland Mines Ltd 2834
GYRE Nasdaq Gyre Therapeutics, Inc. 2834
HCM Nasdaq HUTCHMED (China) Limited 2834
HELP Nasdaq Cybin Inc. 2834
IBIO Nasdaq iBio, Inc. 2834
IMRN Nasdaq Immuron Limited 2834
IMTX Nasdaq Immatics N.V. 2834
IMUX Nasdaq Immunic, Inc. 2834
IMVT Nasdaq Immunovant, Inc. 2834
INDP Nasdaq Indaptus Therapeutics, Inc. 2834
INDV Nasdaq Indivior Pharmaceuticals, Inc. 2834
INKT Nasdaq MiNK Therapeutics, Inc. 2834
IPSEY Over the counter Ipsen S.A. 2834
IRON Nasdaq Disc Medicine, Inc. 2834
JAGX Nasdaq Jaguar Health, Inc. 2834
JANX Nasdaq Janux Therapeutics, Inc. 2834
JHPCY Over the counter Jiangsu Hengrui Pharmaceuticals Co.,Ltd 2834
KAPA NYSE American Kairos Pharma, Ltd. 2834
KPRX Nasdaq Kiora Pharmaceuticals, Inc. 2834
KPTI Nasdaq Karyopharm Therapeutics Inc. 2834
KROS Nasdaq Keros Therapeutics, Inc. 2834
KTTA Nasdaq Pasithea Therapeutics Corp. 2834
KYKOY Over the counter Kyowa Kirin Co., Ltd. 2834
KYTX Nasdaq Kyverna Therapeutics, Inc. 2834
KZIA Nasdaq Kazia Therapeutics Limited 2834
LBRX Nasdaq LB Pharmaceuticals Inc 2834
LCTX NYSE American Lineage Cell Therapeutics, Inc. 2834
LGND Nasdaq Ligand Pharmaceuticals Incorporated 2834
LLY New York Eli Lilly and Company 2834
LQDA Nasdaq Liquidia Corporation 2834
MAIA NYSE American MAIA Biotechnology, Inc. 2834
MANE New York Veradermics, Incorporated 2834
MBRX Nasdaq Moleculin Biotech, Inc. 2834
MDCX Nasdaq Medicus Pharma Ltd. 2834
MIRM Nasdaq Mirum Pharmaceuticals, Inc. 2834
MLYS Nasdaq Mineralys Therapeutics, Inc. 2834
MTVA Nasdaq MetaVia Inc. 2834
MXCT Nasdaq MaxCyte, Inc. 2834
NBIX Nasdaq Neurocrine Biosciences, Inc. 2834
NGEN Nasdaq NervGen Pharma Corp. 2834
NKTR Nasdaq Nektar Therapeutics 2834
NRSN Nasdaq NeuroSense Therapeutics Ltd. 2834
NRXP Nasdaq NRx Pharmaceuticals, Inc. 2834
NTHI Nasdaq NeOnc Technologies Holdings, Inc. 2834
NTLA Nasdaq Intellia Therapeutics, Inc. 2834
OCS Nasdaq Oculis Holding AG 2834
OCUL Nasdaq Ocular Therapeutix, Inc. 2834
ORGO Nasdaq Organogenesis Holdings Inc. 2834
ORMP Nasdaq Oramed Pharmaceuticals Inc. 2834
PCRX Nasdaq Pacira BioSciences, Inc. 2834
Results 50 through 100 of 153